z-logo
open-access-imgOpen Access
Clinical use of vorapaxar as an emerging antithrombin agent: A literature review of current evidence
Author(s) -
Farjah Algahtani
Publication year - 2017
Publication title -
journal of applied hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.107
H-Index - 2
eISSN - 2454-6976
pISSN - 1658-5127
DOI - 10.4103/joah.joah_41_17
Subject(s) - medicine , stroke (engine) , thrombosis , cardiology , revascularization , acute coronary syndrome , platelet aggregation inhibitor , intensive care medicine , myocardial infarction , aspirin , engineering , mechanical engineering

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here